Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 19.04B | 18.38B | 17.80B | 15.27B | 11.53B |
Gross Profit | 1.73B | 1.49B | 1.73B | 495.00M | -2.02B |
EBITDA | 1.31B | 621.00M | 993.00M | -283.00M | -542.00M |
Net Income | 98.00M | -532.00M | 177.00M | 1.82B | -1.72B |
Balance Sheet | |||||
Total Assets | 30.02B | 30.07B | 29.15B | 30.16B | 29.45B |
Cash, Cash Equivalents and Short-Term Investments | 5.86B | 5.87B | 7.10B | 8.61B | 6.49B |
Total Debt | 14.70B | 14.89B | 13.52B | 14.39B | 16.41B |
Total Liabilities | 20.78B | 20.93B | 19.68B | 20.86B | 22.13B |
Stockholders Equity | 9.18B | 9.10B | 9.42B | 9.25B | 7.28B |
Cash Flow | |||||
Free Cash Flow | -139.00M | -1.89B | -213.00M | 629.00M | -1.59B |
Operating Cash Flow | 549.00M | 575.00M | 561.00M | 1.20B | -1.03B |
Investing Cash Flow | 39.00M | -3.15B | -1.16B | 2.67B | -546.00M |
Financing Cash Flow | -886.00M | 830.00M | -1.21B | -2.21B | 6.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥53.43B | 7.62 | 4.39% | 5.04% | 72.34% | ||
72 Outperform | ¥58.33B | 11.58 | 4.90% | 8.88% | -25.45% | ||
72 Outperform | ¥30.62B | 7.91 | 4.64% | -5.73% | -38.92% | ||
63 Neutral | ¥105.13B | 8.20 | 3.87% | 16.28% | 2.80% | ||
62 Neutral | £1.74B | 9.21 | 4.55% | 3.51% | 0.65% | -43.22% | |
54 Neutral | ¥4.21B | 22.59 | 0.84% | 4.95% | ― | ||
49 Neutral | ¥2.73B | 139.38 | 1.52% | 0.91% | -517.75% |